Literature DB >> 14560027

Death receptor-induced activation of initiator caspase 8 is antagonized by serine/threonine kinase PAK4.

Nerina Gnesutta1, Audrey Minden.   

Abstract

Normal cell growth requires a precisely controlled balance between cell death and survival. This involves activation of different types of intracellular signaling cascades within the cell. While some types of signaling proteins regulate apoptosis, or programmed cell death, other proteins within the cell can promote survival. The serine/threonine kinase PAK4 can protect cells from apoptosis in response to several different types of stimuli. As is the case for other members of the p21-activated kinase (PAK) family, one way that PAK4 may promote cell survival is by phosphorylating and thereby inhibiting the proapoptotic protein Bad. This leads in turn to the inhibition of effector caspases such as caspase 3. Here we show that in response to cytokines which activate death domain-containing receptors, such as the tumor necrosis factor and Fas receptors, PAK4 can inhibit the death signal by a different mechanism. Under these conditions, PAK4 inhibits apoptosis early in the caspase cascade, antagonizing the activation of initiator caspase 8. This inhibition, which does not require PAK4's kinase activity, may involve inhibition of caspase 8 recruitment to the death domain receptors. This role in regulating initiator caspases is an entirely novel role for the PAK proteins and suggests a new mechanism by which these proteins promote cell survival.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14560027      PMCID: PMC207651          DOI: 10.1128/MCB.23.21.7838-7848.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  77 in total

1.  c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis.

Authors:  David W Chang; Zheng Xing; Yi Pan; Alicia Algeciras-Schimnich; Bryan C Barnhart; Shoshanit Yaish-Ohad; Marcus E Peter; Xiaolu Yang
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

Review 2.  Social controls on cell survival and cell death.

Authors:  M C Raff
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

3.  Emerging from the Pak: the p21-activated protein kinase family.

Authors:  M A Sells; J Chernoff
Journal:  Trends Cell Biol       Date:  1997-04       Impact factor: 20.808

4.  FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.

Authors:  A M Chinnaiyan; K O'Rourke; M Tewari; V M Dixit
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

5.  The Akt proto-oncogene links Ras to Pak and cell survival signals.

Authors:  Y Tang; H Zhou; A Chen; R N Pittman; J Field
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

6.  Inhibition of death receptor signals by cellular FLIP.

Authors:  M Irmler; M Thome; M Hahne; P Schneider; K Hofmann; V Steiner; J L Bodmer; M Schröter; K Burns; C Mattmann; D Rimoldi; L E French; J Tschopp
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

7.  PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia.

Authors:  A Abo; J Qu; M S Cammarano; C Dan; A Fritsch; V Baud; B Belisle; A Minden
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

8.  The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation.

Authors:  H Hsu; J Xiong; D V Goeddel
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

9.  Cleavage and activation of p21-activated protein kinase gamma-PAK by CPP32 (caspase 3). Effects of autophosphorylation on activity.

Authors:  B N Walter; Z Huang; R Jakobi; P T Tuazon; E S Alnemri; G Litwack; J A Traugh
Journal:  J Biol Chem       Date:  1998-10-30       Impact factor: 5.157

10.  CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly.

Authors:  Russell G Jones; Alisha R Elford; Michael J Parsons; Linda Wu; Connie M Krawczyk; Wen-Chen Yeh; Razqallah Hakem; Robert Rottapel; James R Woodgett; Pamela S Ohashi
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

View more
  39 in total

Review 1.  Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer.

Authors:  Yang-Guang Shao; Ke Ning; Feng Li
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 2.  Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.

Authors:  Byung Hak Ha; Elizabeth M Morse; Benjamin E Turk; Titus J Boggon
Journal:  J Biol Chem       Date:  2015-04-08       Impact factor: 5.157

Review 3.  P21 activated kinases: structure, regulation, and functions.

Authors:  Chetan K Rane; Audrey Minden
Journal:  Small GTPases       Date:  2014-03-21

4.  Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth.

Authors:  Brion W Murray; Chuangxing Guo; Joseph Piraino; John K Westwick; Cathy Zhang; Jane Lamerdin; Eleanor Dagostino; Daniel Knighton; Cho-Ming Loi; Michael Zager; Eugenia Kraynov; Ian Popoff; James G Christensen; Ricardo Martinez; Susan E Kephart; Joseph Marakovits; Shannon Karlicek; Simon Bergqvist; Tod Smeal
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

Review 5.  PAK signalling during the development and progression of cancer.

Authors:  Maria Radu; Galina Semenova; Rachelle Kosoff; Jonathan Chernoff
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

6.  Do PAKs make good drug targets?

Authors:  Zhuo-Shen Zhao; Ed Manser
Journal:  F1000 Biol Rep       Date:  2010-09-23

7.  The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis.

Authors:  Y Liu; N Chen; X Cui; X Zheng; L Deng; S Price; V Karantza; A Minden
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

Review 8.  PAK thread from amoeba to mammals.

Authors:  Anupam Kumar; Poonam R Molli; Suresh B Pakala; Tri M Bui Nguyen; Suresh K Rayala; Rakesh Kumar
Journal:  J Cell Biochem       Date:  2009-07-01       Impact factor: 4.429

9.  Human Testis Phosphoproteome Reveals Kinases as Potential Targets in Spermatogenesis and Testicular Cancer.

Authors:  Judit Castillo; Jaco C Knol; Cindy M Korver; Sander R Piersma; Thang V Pham; Richard R de Goeij-de Haas; Ans M M van Pelt; Connie R Jimenez; Bastiaan J H Jansen
Journal:  Mol Cell Proteomics       Date:  2019-01-25       Impact factor: 5.911

Review 10.  PAK signaling in oncogenesis.

Authors:  P R Molli; D Q Li; B W Murray; S K Rayala; R Kumar
Journal:  Oncogene       Date:  2009-05-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.